CA2027736A1 - Traitement des maladies reliees aux hormones males a l'aide des cyclodextrines et de leurs derives - Google Patents

Traitement des maladies reliees aux hormones males a l'aide des cyclodextrines et de leurs derives

Info

Publication number
CA2027736A1
CA2027736A1 CA2027736A CA2027736A CA2027736A1 CA 2027736 A1 CA2027736 A1 CA 2027736A1 CA 2027736 A CA2027736 A CA 2027736A CA 2027736 A CA2027736 A CA 2027736A CA 2027736 A1 CA2027736 A1 CA 2027736A1
Authority
CA
Canada
Prior art keywords
treatment
cyclodextrins
derivatives
male hormone
related diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2027736A
Other languages
English (en)
Other versions
CA2027736C (fr
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ueno Seiyaku Oyo Kenkyujo KK
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of CA2027736A1 publication Critical patent/CA2027736A1/fr
Application granted granted Critical
Publication of CA2027736C publication Critical patent/CA2027736C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002027736A 1989-10-18 1990-10-16 Traitement des maladies reliees aux hormones males a l'aide des cyclodextrines et de leurs derives Expired - Fee Related CA2027736C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP27442489 1989-10-18
JP274424/1989 1989-10-18
JP29809089 1989-11-15
JP298090/1989 1989-11-15

Publications (2)

Publication Number Publication Date
CA2027736A1 true CA2027736A1 (fr) 1991-04-19
CA2027736C CA2027736C (fr) 2000-03-21

Family

ID=26551032

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002027736A Expired - Fee Related CA2027736C (fr) 1989-10-18 1990-10-16 Traitement des maladies reliees aux hormones males a l'aide des cyclodextrines et de leurs derives

Country Status (5)

Country Link
US (1) US5206224A (fr)
EP (1) EP0431736B1 (fr)
AT (1) ATE117554T1 (fr)
CA (1) CA2027736C (fr)
DE (1) DE69016381T2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69232220D1 (de) * 1992-09-22 2002-01-03 Takeo Takayanagi Kohlenhydrate-Komplexe zur Vernichtung von Krebszellen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258180A (en) * 1979-11-05 1981-03-24 American Cyanamid Company C6-Modified cyclodextrin sulfate salts as complement inhibitors
JPS5910525A (ja) * 1982-06-21 1984-01-20 Teisan Seiyaku Kk プロスタグランジンｅの安定化組成物
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.

Also Published As

Publication number Publication date
DE69016381D1 (de) 1995-03-09
US5206224A (en) 1993-04-27
EP0431736B1 (fr) 1995-01-25
DE69016381T2 (de) 1995-05-24
EP0431736A1 (fr) 1991-06-12
CA2027736C (fr) 2000-03-21
ATE117554T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
CA2039197A1 (fr) Formule pharmaceutique pour le traitement de l'alcoolisme
CA2071623A1 (fr) Composition a base de cyclodextrine
EP0337256A3 (fr) Procédé de préparation de compositions pharmaceutiques
CA2093806A1 (fr) Methode de traitement ou de prevention du diabete de type 1 par l'administration orale d'insuline
AU1266288A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
CA2041417A1 (fr) Traitement d'une maladie du pancreas a l'aide de composes de 15-ceto-prostaglandine
CA2046069A1 (fr) Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
AU661591B2 (en) 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
CA2027814A1 (fr) Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin
AU5060090A (en) Pharmaceutical treatment
CA2042934A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique oculaire
CA2123367A1 (fr) Composition pharmaceutique anti-allergique pour administration ophtalmique topique
CA2027736A1 (fr) Traitement des maladies reliees aux hormones males a l'aide des cyclodextrines et de leurs derives
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
CA2030344A1 (fr) Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
CA2041240A1 (fr) Traitement biochimique a l'aide de 15-deshydroxy-16-oxoprostaglandine
CA2003981A1 (fr) Composes pharmaceutiques utiles dans le traitement du psoriasis
AU4545289A (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
CA2027743A1 (fr) Diurese au moyen des cyclodextrines et de leurs derives
CA2048245A1 (fr) Traitement de la cataracte avec des composes a base de prostacycline
AU633196B2 (en) Methods for the treatment of demyelinating disease, uveitis, or graft-versus-host disease
CA2101548A1 (fr) Acides acylamino-alylidenehydroxy-bisphosphoniques, utiles pour le traitement des maladies osteoarticulaires
CA2022372A1 (fr) Excretion d'azote non proteique dans l'intestin par des derives de l'acide prostanoique
ES2026755A6 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
CA2022081A1 (fr) Traitement de l'hyperlipidemie a l'aide de composes de 15-ceto-prostaglandine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed